1. Home
  2. Polycythemia Vera (PV)
  3. How is polycythemia vera (PV) managed and treated? — Expert Video
Understanding and Diagnosing Polycythemia Vera (PV) — Animation
Understanding and Diagnosing Polycythemia Vera (PV) — Animation
Managing and Treating Polycythemia Vera (PV) — Animation
Managing and Treating Polycythemia Vera (PV) — Animation
Understanding and Diagnosing Polycythemia Vera (PV) — Slide Show
Understanding and Diagnosing Polycythemia Vera (PV) — Slide Show
Managing and Treating Polycythemia Vera (PV) — Slide Show
Managing and Treating Polycythemia Vera (PV) — Slide Show
Expert Videos
What is polycythemia vera (PV)?
1. What is polycythemia vera (PV)?
Why and how did my polycythemia vera (PV) arise?
2. Why and how did my polycythemia vera (PV) arise?
How is polycythemia vera (PV) diagnosed?
3. How is polycythemia vera (PV) diagnosed?
What are the signs, symptoms, and expectations of living with PV?
4. What are the signs, symptoms, and expectations of living with PV?
What are the risks with polycythemia vera (PV)?
5. What are the risks with polycythemia vera (PV)?
How is polycythemia vera (PV) managed and treated?
6. How is polycythemia vera (PV) managed and treated?
Patient Videos
Dana's story: How did you find out you had polycythemia vera (PV)?
7. Dana's story: How did you find out you had polycythemia vera (PV)?
Dana's story: What challenges and successes have you had with PV treatment?
8. Dana's story: What challenges and successes have you had with PV treatment?
Dana's story: What advice do you have for others on their journey with PV?
9. Dana's story: What advice do you have for others on their journey with PV?

How is polycythemia vera (PV) managed and treated? — Expert Video

In this video, Dr. John Mascarenhas explains how polycythemia vera (PV) is managed and treated. He emphasizes that all patients benefit from low-dose aspirin and therapeutic phlebotomy to reduce hematocrit. High-risk patients (such as those over 60 or with prior blood clots) may also need medications to lower blood counts. Dr. Mascarenhas highlights the importance of personalized care, symptom management, and clear communication with a knowledgeable care team. He also provides an overview of emerging therapies and research that aim to improve outcomes and potentially alter disease progression.

  • Share with family and friends:

Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about myeloproliferative neoplasms which will help other patients, caregivers, and families.

Other Modules:

Understanding MPNs

Understanding MPNs

Essential Thrombocythemia (ET)

Essential Thrombocythemia (ET)

Myelofibrosis (MF)

Myelofibrosis (MF)

Understanding and Diagnosing Polycythemia Vera (PV) — Animation
Understanding and Diagnosing Polycythemia Vera (PV) — Animation
Managing and Treating Polycythemia Vera (PV) — Animation
Managing and Treating Polycythemia Vera (PV) — Animation
Understanding and Diagnosing Polycythemia Vera (PV) — Slide Show
Understanding and Diagnosing Polycythemia Vera (PV) — Slide Show
Managing and Treating Polycythemia Vera (PV) — Slide Show
Managing and Treating Polycythemia Vera (PV) — Slide Show
Expert Videos
What is polycythemia vera (PV)?
1. What is polycythemia vera (PV)?
Why and how did my polycythemia vera (PV) arise?
2. Why and how did my polycythemia vera (PV) arise?
How is polycythemia vera (PV) diagnosed?
3. How is polycythemia vera (PV) diagnosed?
What are the signs, symptoms, and expectations of living with PV?
4. What are the signs, symptoms, and expectations of living with PV?
What are the risks with polycythemia vera (PV)?
5. What are the risks with polycythemia vera (PV)?
How is polycythemia vera (PV) managed and treated?
6. How is polycythemia vera (PV) managed and treated?
Patient Videos
Dana's story: How did you find out you had polycythemia vera (PV)?
7. Dana's story: How did you find out you had polycythemia vera (PV)?
Dana's story: What challenges and successes have you had with PV treatment?
8. Dana's story: What challenges and successes have you had with PV treatment?
Dana's story: What advice do you have for others on their journey with PV?
9. Dana's story: What advice do you have for others on their journey with PV?

Other Modules:

Understanding MPNs

Understanding MPNs

Essential Thrombocythemia (ET)

Essential Thrombocythemia (ET)

Myelofibrosis (MF)

Myelofibrosis (MF)

 

This educational activity has been developed by MPN Research Foundation in collaboration with Mechanisms in Medicine Inc.

This activity is supported by independent educational grants from Disc Medicine, GSK, Incyte, Merck, PharmaEssentia, Sumitomo Pharma, and Takeda.

We are also deeply grateful to the individual donors whose generosity supports the MPN Research Foundation's mission and programs like this one.

Thank you to the funders of You And MPN. All content is developed independently by MPN Research Foundation and Mechanisms in Medicine Inc., in collaboration with an Expert Faculty group; funders are allowed no influence on the content of You And MPN: Animated Patient® Guide to Myeloproliferative Neoplasms.

Disclaimer: The information provided is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always consult your doctor about any questions you may have regarding a medical condition. The visuals provided are meant to be representations only. No specific brand is being promoted or endorsed.

Copyright © Mechanisms in Medicine Inc. All rights reserved.

This website is part of the Animated Patient® series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.